skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

10 Total results for product and free and sample content found

Skipta Case Studies: New Disease, same trusted social platform

With the COVID-19 pandemic raging, verified HCPs are turning to Skipta more than ever to access clinically relevant information reaching beyond the crisis. Find out how other brand managers engaged these members using Skipta’s disease-specific micro-communities.

Topic Neurology Market Intelligence

awareness, thought-leadership, Scrip: 世界の医療用医...

Scrip Asia 100: Sponsorship Opportunities

MS Scrip Asia 100 Sample Chapter Cover Image

The annual “Scrip Asia 100”, the highly anticipated financial performance ranking of pharma companies headquartered in the APAC region, is coming soon. Don’t miss your opportunity to position yourself as a leader in APAC pharma with a sponsorship in this indispensable publication.  

Topic company-analysis Market Intelligence Outlook

awareness, lead-generation, our-products-and-...

Powering Pharma and Medtech To Make Effective Clinical Regulatory and Commercial Decisions

With deep Pharma industry and marketing expertise, we can help you to reach Pharma’s elusive decision makers with relevant high-impact and engaging content, so you can reach your business and revenue objectives.  

Topic Market Intelligence

awareness

Developing high quality content for the pharma industry

Developing high quality content for the pharma industry

To reach today’s Pharma decision makers, you must provide the right high-quality content to help them make educated purchasing decisions – and become loyal customers.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip's Rough Guide On The State Of RNAi

The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.

HBW Insight : コンシューマーヘルスケア産業のニュース

EU Wellness Market In 2019: The CBD Green Rush

An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip Asks...What Does 2020 Hold For Biopharma? Part 1: Therapeutic Advances

Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making biopharma an exciting place to be in 2020.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip Asia 100 Report Extract

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。